RNMBY Riches: Susie Lee’s Defense Deal or Shady Steal?
Unpacking the Hype Around a Congresswoman’s Defense Stock Triumph
Buckle up, stock market sleuths! A viral X post from @PelosiTracker_ has set tongues wagging, claiming that following Rep. Susie Lee’s 2024 purchase of Rheinmetall AG ($RNMBY) could’ve netted you a jaw-dropping 330% return by now. But is this German defense stock really a golden ticket, or are we chasing a congressional mirage? Let’s dive into the numbers, the controversy, and why this story has investors and ethicists buzzing.
The Viral Claim That Caught Fire
In May 2024, @PelosiTracker_, the self-appointed watchdog of congressional stock trades, flagged a curious move by Nevada’s Rep. Susie Lee. The Democratic congresswoman snapped up shares of Rheinmetall AG ($RNMBY), a German powerhouse in weapons manufacturing, in a trade valued between $1,001 and $15,000. Why the raised eyebrows? Two reasons:
- No Politician Had Touched RNMBY Before – Lee was the first to dip her toes into this stock, per congressional records.
- Her Committee Seat Screams Conflict – As a member of the House Subcommittee on Military Construction, Veterans Affairs, and Related Agencies, Lee’s role intersects with defense spending, making her stock pick a lightning rod for scrutiny.
Fast-forward to May 2025, and @PelosiTracker_ crowed that anyone who followed Lee’s trade would be up 330%. Cue the champagne—or maybe not. Let’s crunch the numbers to see if this claim holds water.
The Real Numbers: 247% Gain, Not 330%
According to congressional trade reports from Capitol Trades and Quiver Quantitative, Lee bought RNMBY on May 10, 2024, at $115.347 per share. As of 9:05 AM PDT on May 20, 2025, Yahoo Finance pegs RNMBY at $400.50. Let’s do the math:
- Purchase Price: $115.347
- Current Price: $400.50
- Gain: ($400.50 - $115.347) / $115.347 × 100 = 247.2%
That’s a stellar return—enough to make any investor’s heart skip a beat—but it’s a far cry from the 330% hyped in the X post. To hit 330%, the purchase price would’ve needed to be around $93.14, but no data supports this. The discrepancy? Likely a mix of exaggeration and sloppy math, a classic social media cocktail designed to grab eyeballs.
Why Rheinmetall? The Defense Stock Surge
Rheinmetall AG, a titan in defense manufacturing, has been riding high. With global tensions fueling demand for military hardware, RNMBY’s stock has soared from a 52-week low of $101.13 to a high of $401.00, per Yahoo Finance. Lee’s purchase timing was impeccable, but was it luck, skill, or something murkier? Her subcommittee role raises questions, as it oversees military construction budgets that could indirectly benefit defense contractors like Rheinmetall.
The controversy isn’t new. Congressional stock trading has long been a hot potato, with critics arguing that lawmakers’ access to privileged information gives them an unfair edge. The STOCK Act of 2012 mandates timely trade disclosures, but enforcement has been spotty, and Lee’s RNMBY buy has reignited the debate. As Nevada News and Views noted, her trades have drawn attention from figures like Dave Portnoy, who called her stock-picking prowess “too good to ignore.”
Should You Follow Politicians’ Trades?
The allure of mimicking congressional portfolios is undeniable—247% returns don’t grow on trees. Platforms like Quiver Quantitative and Capitol Trades make it easy to track these moves, and @PelosiTracker_ has built a cult following by spotlighting them. But before you YOLO your savings into RNMBY, consider the risks:
- Past Performance Isn’t a Crystal Ball: A hot stock today could tank tomorrow.
- Ethical Quagmires: Following trades tied to potential conflicts of interest might not sit well with your conscience.
- Delayed Reporting: Congressional disclosures often lag, meaning you’re buying at a different price than the politician.
The Bigger Picture: Ethics vs. Profits
Susie Lee’s RNMBY trade, while profitable, underscores a broader issue: should lawmakers be allowed to trade stocks at all? Critics argue for bans, citing the appearance of insider trading, while defenders claim it’s their right as private citizens. With no concrete evidence of wrongdoing in Lee’s case, the debate rages on, fueled by posts like @PelosiTracker_’s that blend fact with flair.
Final Verdict: A Win, But Not That Big
Rep. Susie Lee’s Rheinmetall bet was a home run, delivering a 247% gain in just over a year—an enviable return for any investor. But the 330% claim? That’s a stretch, and @PelosiTracker_ owes us a fact-check. Whether you see Lee as a stock-picking savant or a symbol of congressional privilege, one thing’s clear: her trade has sparked a conversation that’s not going away.
So, will you chase the next congressional stock tip, or steer clear of the ethical gray zone?
Sources: Yahoo Finance, Capitol Trades, Quiver Quantitative, Nevada News and Views, The Nevada Globe